Infliximab preferentially induces clinical remission and mucosal healing in short course Crohn's disease with luminal lesions through balancing abnormal immune response in gut mucosa
about
Divalent metal-ion transporter 1 is decreased in intestinal epithelial cells and contributes to the anemia in inflammatory bowel disease.Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel DiseaseSystematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's Disease.Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease.
P2860
Infliximab preferentially induces clinical remission and mucosal healing in short course Crohn's disease with luminal lesions through balancing abnormal immune response in gut mucosa
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Infliximab preferentially indu ...... immune response in gut mucosa
@ast
Infliximab preferentially indu ...... immune response in gut mucosa
@en
type
label
Infliximab preferentially indu ...... immune response in gut mucosa
@ast
Infliximab preferentially indu ...... immune response in gut mucosa
@en
prefLabel
Infliximab preferentially indu ...... immune response in gut mucosa
@ast
Infliximab preferentially indu ...... immune response in gut mucosa
@en
P2093
P2860
P356
P1476
Infliximab preferentially indu ...... immune response in gut mucosa
@en
P2093
Hongchun Liu
Jianxin Wu
Wensong Ge
Xuehua Yang
Zhanju Liu
P2860
P304
P356
10.1155/2015/793764
P577
2015-03-19T00:00:00Z